Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NDUFB9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DPP10-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HSPB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FADS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACTG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STON2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YBEY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR34-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QPRT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL12RB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFI30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPCAT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLIPR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLBD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on